Original Research
Published on 06 Aug 2020
Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade® to Remsima®? An Observational Study
in Rheumatology
Frontiers in Medicine
doi 10.3389/fmed.2020.00418
- 6,552 views
- 11 citations
